Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 250 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2020-12-03 | 2021-05-20 | 129530 |
| TEVA-ZOPICLONE | 7.5MG | TABLET | Resolved | 2020-12-17 | 2021-06-03 | 130282 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-12-17 | 2021-01-21 | 130296 |
| TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2020-12-17 | 2021-07-09 | 130301 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Resolved | 2020-12-17 | 2021-02-05 | 130304 |
| TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2020-12-17 | 2021-02-05 | 130307 |
| TEVA-LISINOPRIL (TYPE Z) | 20MG | TABLET | Resolved | 2020-12-17 | 2021-02-05 | 130310 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 20MG 25MG | TABLET | Resolved | 2020-12-17 | 2020-12-18 | 130313 |
| TEVA-LISINOPRIL (TYPE Z) | 5MG | TABLET | Resolved | 2020-12-17 | 2021-07-09 | 130316 |
| TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Resolved | 2020-12-17 | 2021-02-12 | 130319 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-07 | 2021-01-14 | 131069 |
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2021-01-07 | 2021-02-05 | 131078 |
| TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2021-01-07 | 2021-03-04 | 131081 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 20MG 12.5MG | TABLET | Resolved | 2021-01-07 | 2021-03-25 | 131087 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 20MG 25MG | TABLET | Resolved | 2021-01-07 | 2021-01-14 | 131090 |
| ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2021-01-15 | 2021-05-20 | 131673 |
| TEVA-OXYCODAN | 325MG 5MG | TABLET | Resolved | 2021-01-15 | 2021-03-04 | 131685 |
| TEVA-GABAPENTIN | 800MG | TABLET | Resolved | 2021-01-15 | 2021-02-11 | 131694 |
| TEVA-LISINOPRIL (TYPE Z) | 5MG | TABLET | Resolved | 2021-01-15 | 2021-02-05 | 131697 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 10MG 12.5MG | TABLET | Resolved | 2021-01-15 | 2021-02-05 | 131700 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |